Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Titan Pharmaceuticals Inc (NASDAQ:TTNP)

5.54
Delayed Data
As of Aug 29
 +0.07 / +1.28%
Today’s Change
2.57
Today|||52-Week Range
10.00
+24.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash18.1M11.8M15.5M7.9M
 
 
 
 
 
Short Term Investment Cash12.7M-6.3M3.7M-7.6M
 
 
 
 
 
Cash & Short Term Investments18.1M11.8M15.5M7.9M
 
 
 
 
 
 
ReceivablesReceivables4.6M4.8M4.0M4.2M
 
 
 
 
 
 
InventoriesInventories0.000.00--0.00--
 
Current AssetsOther Current Assets687.0K204.0K145.0K174.0K
 
 
 
 
 
Current Assets23.4M16.8M19.6M12.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross3.8M4.2M4.2M4.3M
 
 
 
 
 
Depreciation-2.4M-2.6M-2.9M-3.3M
 
 
 
 
 
Other Assets0.000.000.000.00--
Total Assets24.8M18.4M20.9M13.3M
 
 
 
 
 
 
LiabilitiesAccounts Payable3.8M5.1M4.4M4.2M
 
 
 
 
 
Short Term Debt2.5M0.000.000.00
 
 
Accrued Expenses751.0K411.0K583.0K695.0K
 
 
 
 
 
Other Current Liabilities15.1M5.7M2.3M695.0K
 
 
 
 
 
Other Liabilities21.4M10.8M6.7M4.9M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt9.4M0.000.000.00
 
 
Other Liabilities17.2M1.8M5.6M1.4M
 
 
 
 
 
Total Liabilities48.0M12.7M12.2M6.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity-23.1M5.8M8.6M7.0M
 
 
 
 
 
Total Shareholder Equity-23.1M5.8M8.6M7.0M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding13.7M16.1M20.0M20.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.